These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24961209)

  • 1. Misfolded proteins in Huntington disease fetal grafts: further evidence of cell-to-cell transfer?
    Kordower JH; Halliday G
    Ann Neurol; 2014 Jul; 76(1):20-1. PubMed ID: 24961209
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutant huntingtin is present in neuronal grafts in Huntington disease patients.
    Cicchetti F; Lacroix S; Cisbani G; Vallières N; Saint-Pierre M; St-Amour I; Tolouei R; Skepper JN; Hauser RA; Mantovani D; Barker RA; Freeman TB
    Ann Neurol; 2014 Jul; 76(1):31-42. PubMed ID: 24798518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hunting down huntingtin.
    Aronin N; Moore M
    N Engl J Med; 2012 Nov; 367(18):1753-4. PubMed ID: 23113488
    [No Abstract]   [Full Text] [Related]  

  • 4. Taking a break from huntingtin.
    Davidson BL
    Mol Ther; 2012 Oct; 20(10):1838. PubMed ID: 23023055
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversing neurodegeneration: a promise unfolds.
    Orr HT; Zoghbi HY
    Cell; 2000 Mar; 101(1):1-4. PubMed ID: 10778849
    [No Abstract]   [Full Text] [Related]  

  • 6. Huntington disease: pathogenesis and treatment.
    Dayalu P; Albin RL
    Neurol Clin; 2015 Feb; 33(1):101-14. PubMed ID: 25432725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Huntington chorea: genetics and biochemistry, diagnosis and therapy].
    Borbás T; Hegyesi H
    Acta Pharm Hung; 2002; 72(2):127-36. PubMed ID: 12498040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untangling huntingtin's mysteries.
    Nat Med; 2000 Oct; 6(10):1063. PubMed ID: 11017110
    [No Abstract]   [Full Text] [Related]  

  • 9. [Huntington disease].
    Kwak S
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():417-21. PubMed ID: 12013902
    [No Abstract]   [Full Text] [Related]  

  • 10. Lentiviral-mediated gene transfer of siRNAs for the treatment of Huntington's disease.
    Cambon K; Déglon N
    Methods Mol Biol; 2013; 1010():95-109. PubMed ID: 23754221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huntington disease and the huntingtin protein.
    Zheng Z; Diamond MI
    Prog Mol Biol Transl Sci; 2012; 107():189-214. PubMed ID: 22482451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
    Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F
    Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huntington disease.
    Bates GP; Dorsey R; Gusella JF; Hayden MR; Kay C; Leavitt BR; Nance M; Ross CA; Scahill RI; Wetzel R; Wild EJ; Tabrizi SJ
    Nat Rev Dis Primers; 2015 Apr; 1():15005. PubMed ID: 27188817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntington's disease: getting closer.
    Greenamyre JT
    Am J Psychiatry; 2007 Sep; 164(9):1318. PubMed ID: 17728414
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of novel therapies for Huntington's disease: hope and challenge.
    Qin ZH; Wang J; Gu ZL
    Acta Pharmacol Sin; 2005 Feb; 26(2):129-42. PubMed ID: 15663888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategies for Huntington's disease based on a molecular understanding of the disorder.
    Haque NS; Borghesani P; Isacson O
    Mol Med Today; 1997 Apr; 3(4):175-83. PubMed ID: 9134531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Huntingtin's critical cleavage.
    Fryer JD; Zoghbi HY
    Nat Neurosci; 2006 Sep; 9(9):1088-9. PubMed ID: 16936769
    [No Abstract]   [Full Text] [Related]  

  • 18. [Huntington disease].
    Nukina N
    Rinsho Shinkeigaku; 1997 Dec; 37(12):1139-40. PubMed ID: 9577671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of neuronal death in Huntington's disease. First part: general considerations and histopathological features].
    Bantubungi K; Blum D
    Rev Med Brux; 2007; 28(5):413-21. PubMed ID: 18069515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing formation of toxic N-terminal huntingtin fragments through antisense oligonucleotide-mediated protein modification.
    Evers MM; Tran HD; Zalachoras I; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Nucleic Acid Ther; 2014 Feb; 24(1):4-12. PubMed ID: 24380395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.